BioAge Labs (BIOA) Change in Account Payables (2023 - 2026)
BioAge Labs (BIOA) posted Change in Account Payables of $326000.0 for Q1 2026, up 114.13% sequentially from -$2.3 million in Q4 2025, and down 84.07% YoY from $2.0 million in Q1 2025.
BioAge Labs (BIOA) Change in Account Payables (2023 - 2026) Analysis & Trends
BioAge Labs has reported Change in Account Payables for 4 years, with the latest figure at $326000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 84.07% year-over-year to $326000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$933000.0 (down 155.14% YoY) and the FY2025 annual result came in at $788000.0, up 13033.33% from the prior year.
- Change in Account Payables rose to $326000.0 in Q1 2026 per BIOA's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $3.6 million in Q3 2025 and troughed at -$2.6 million in Q2 2025.
- A 4-year average of $243200.0 and a median of $343500.0 in 2024 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 467.04% in 2025, down 1730.95% in 2025.
- Over 4 years, Change in Account Payables stood at $1.3 million in 2023, then plunged by 109.6% to -$126000.0 in 2024, then tumbled by 1730.95% to -$2.3 million in 2025, then jumped by 114.13% to $326000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $326000.0, -$2.3 million, and $3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | BioAge Labs | 427.31 Mn | 427.31 Mn | -14.23 Mn | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 326,000.00 |
| Mar 31, 2026 | 326,000.00 |
| Dec 31, 2025 | -2.31 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | -2.60 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | -126,000.00 |
| Dec 31, 2024 | -126,000.00 |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | 361,000.00 |
| Mar 31, 2024 | 361,000.00 |